MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock and...
$15,880K
Proceeds from issuance of
common stock-At The...
$10,169K
Proceeds from the
exercise of stock options
$8K
Net cash provided by
financing activities
$26,057K
Effect of foreign
currency on cash
$6K
Net increase in cash
and cash...
$21,470K
Canceled cashflow
$4,593K
Loss on
extinguishment of financial...
-$1,616K
Stock-based compensation
$1,077K
Accounts payable
$896K
Accrued expenses
$162K
Non-cash interest
expense
$125K
Amortization of debt issuance
costs
$64K
Non-cash lease expense
$56K
Depreciation and
amortization
$18K
Other current
liabilities
$6K
Net cash used in
operating activities
-$4,568K
Net cash used in
investing activities
-$25K
Canceled cashflow
$4,020K
Net loss
-$6,898K
Purchase of equipment
$25K
Change in fair value of
liability classified...
-$1,134K
Prepaid expenses and
other current assets
$500K
Operating lease
liabilities
-$56K
Back
Back
Cash Flow
Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc. (SER)
source: myfinsight.com